These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22024355)

  • 1. BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells.
    Maegdefrau U; Bosserhoff AK
    Exp Mol Pathol; 2012 Feb; 92(1):74-81. PubMed ID: 22024355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of BMPs/Smad signaling pathway in mechanical response in osteoblasts.
    Wang L; Zhang X; Guo Y; Chen X; Li R; Liu L; Shi C; Guo C; Zhang Y
    Cell Physiol Biochem; 2010; 26(6):1093-102. PubMed ID: 21220940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WSS25 inhibits growth of xenografted hepatocellular cancer cells in nude mice by disrupting angiogenesis via blocking bone morphogenetic protein (BMP)/Smad/Id1 signaling.
    Qiu H; Yang B; Pei ZC; Zhang Z; Ding K
    J Biol Chem; 2010 Oct; 285(42):32638-46. PubMed ID: 20679340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression.
    Braig S; Bosserhoff AK
    Oncogene; 2013 Feb; 32(7):837-48. PubMed ID: 22469980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential roles of bone morphogenetic protein (BMP)-9 in human liver diseases.
    Herrera B; Dooley S; Breitkopf-Heinlein K
    Int J Mol Sci; 2014 Mar; 15(4):5199-220. PubMed ID: 24670474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
    Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP signaling regulates PGC numbers and motility in organ culture.
    Dudley BM; Runyan C; Takeuchi Y; Schaible K; Molyneaux K
    Mech Dev; 2007 Jan; 124(1):68-77. PubMed ID: 17112707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells.
    Ono Y; Calhabeu F; Morgan JE; Katagiri T; Amthor H; Zammit PS
    Cell Death Differ; 2011 Feb; 18(2):222-34. PubMed ID: 20689554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells.
    Boergermann JH; Kopf J; Yu PB; Knaus P
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1802-7. PubMed ID: 20691279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse bone morphogenetic protein expression profiles and smad pathway activation in different phenotypes of experimental canine mammary tumors.
    Wensman H; Heldin NE; Pejler G; Hellmén E
    PLoS One; 2009 Sep; 4(9):e7133. PubMed ID: 19771160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer.
    Guo D; Huang J; Gong J
    Mol Cell Biochem; 2012 Apr; 363(1-2):179-90. PubMed ID: 22167620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.
    Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H
    Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
    J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
    J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions.
    Kloen P; Lauzier D; Hamdy RC
    Bone; 2012 Jul; 51(1):59-68. PubMed ID: 22521262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.